Skip to main content

Table 3 Baseline features

From: Bleeding outcomes associated with rivaroxaban and dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysis

Studies Mean age Males (%) Ht (%) Ds (%) Cs (%) DM (%)
  R/D R/D R/D R/D R/D R/D
Gorst 2016 [8]
Larock 2014 [9]
Maura 2015 [10]
Providencia 2014 [11]
Sherid 2014 [12]
77.8/73.4
73.0/75.0
73.6/74.0
60.1/59.8
68.3/72.7
45.7/53.4
62.0/66.0
55.0/54.0
73.9/75.1
47.6/50.2
36.8/32.1
71.0/71.0
78.0/80.0
39.4/30.1
-
-
-
47.0/47.0
-
-
-
-
3.0/4.0
-
-
15.6/13.5
20.0/20.0
19.0/19.0
9.0/6.3
-
  1. Abbreviations: R rivaroxaban, D dabigatran, Ht hypertension, Ds dyslipidemia, Cs current smoker, DM diabetes mellitus